{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:03:55Z","timestamp":1648767835791},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T00:00:00Z","timestamp":1257897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00108-009-2465-0","type":"journal-article","created":{"date-parts":[[2009,11,9]],"date-time":"2009-11-09T22:33:28Z","timestamp":1257806008000},"page":"1337-1344","source":"Crossref","is-referenced-by-count":1,"title":["Pr\u00e4vention des Schlaganfalls"],"prefix":"10.1007","volume":"50","author":[{"given":"S.","family":"L\u00fcders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,11]]},"reference":[{"key":"2465_CR1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.STR.0000258004.64840.0b","volume":"38","author":"Akins","year":"2007","unstructured":"Akins PT, Feldman HA, Zoble RG et al. (2007) Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke 38: 874\u2013880","journal-title":"Stroke"},{"key":"2465_CR2","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/01.STR.0000147965.52712.fa","volume":"35","author":"Amarenco","year":"2004","unstructured":"Amarenco P, Labreuche J, Lavallee P et al. (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35: 2902\u20132909","journal-title":"Stroke"},{"key":"2465_CR3","first-page":"71","volume":"524","author":"Antithrombotic","year":"2002","unstructured":"Antithrombotic Trialists\u2018 Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 524: 71\u201386","journal-title":"BMJ"},{"key":"2465_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(04)00800-2","volume":"3","author":"Bonita","year":"2004","unstructured":"Bonita R, Mendis S, Truelsen T et al. (2004) The Global Stroke Initiative. Lancet Neurol 3: 391\u2013393","journal-title":"Lancet Neurol"},{"key":"2465_CR5","first-page":"331","volume":"2","author":"Burry","year":"2002","unstructured":"Burry K (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women\u2019s Health Initiative randomized controlled trial. Curr Womens Health Rep 2: 331\u2013332","journal-title":"Curr Womens Health Rep"},{"key":"2465_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","volume":"371","author":"Cholesterol","year":"2008","unstructured":"Cholesterol Treatment Trialists\u2018 Collaborators (2008) Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371: 117\u2013125","journal-title":"Lancet"},{"key":"2465_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","volume":"357","author":"Collaborative","year":"2001","unstructured":"Collaborative Group of the Primary Prevention Project (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357: 89\u201395","journal-title":"Lancet"},{"key":"2465_CR8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al. (2009) RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361: 1139\u20131151","journal-title":"N Engl J Med"},{"key":"2465_CR9","unstructured":"Kommission Leitlinien der Deutschen Gesellschaft f\u00fcr Neurologie (Hrsg) (2008) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie, 4. Aufl. Thieme, Stuttgart"},{"key":"2465_CR10","unstructured":"Deutsche Hochdruckliga, Deutsche Hypertonie Gesellschaft (2008) Leitlinien zur Therapie der arteriellen Hypertonie. http:\/\/leitlinien.net\/046-001.pdf"},{"key":"2465_CR11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"Diener","year":"2004","unstructured":"Diener H, Bogousslavsky J, Brass L et al. (2004) Acetylsalicylic acid on a background of clopidogrel in high-risk patients randomised after recent ischaemic stroke or transient ischaemic attack: The MATCH trial results. Lancet 364: 331\u2013334","journal-title":"Lancet"},{"key":"2465_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","volume":"369","author":"Elliot","year":"2007","unstructured":"Elliot WJ, Meyer PM (2007) Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 369: 201\u2013207","journal-title":"Lancet"},{"key":"2465_CR13","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/01.STR.0000240690.69406.28","volume":"37","author":"Endres","year":"2006","unstructured":"Endres M, Laufs U (2006) Discontinuation of statin treatment in stroke patients. Stroke 37: 2640\u20132643","journal-title":"Stroke"},{"key":"2465_CR14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.jcbfm.9600116","volume":"25","author":"Endres","year":"2005","unstructured":"Endres M (2005) Statins and stroke. J Cereb Blood Flow Metab 25: 1093\u20131110","journal-title":"J Cereb Blood Flow Metab"},{"key":"2465_CR15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000047700","volume":"12","author":"Eriksson","year":"2001","unstructured":"Eriksson SE, Olsson JE (2001) Survival and recurrent strokes in patients with different subtypes of stroke: a fourteen-year follow-up study. Cerebrovasc Dis 12: 171\u2013180","journal-title":"Cerebrovasc Dis"},{"key":"2465_CR16","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W et al. (2001) Validation of clinical classification schemes for predicting stroke results from the national registry of atrial fibrillation. JAMA 285: 2864\u20132870","journal-title":"JAMA"},{"key":"2465_CR17","first-page":"8","volume":"117","author":"Gerstein","year":"2001","unstructured":"Gerstein HC (2001) Diabetes and the HOPE study: implications for macrovascular and microvascular disease. Int J Clin Pract Suppl 117: 8\u201312","journal-title":"Int J Clin Pract Suppl"},{"key":"2465_CR18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","volume":"6","author":"Giles","year":"2007","unstructured":"Giles MF, Rothwell PM (2007) Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 6: 1063\u20131072","journal-title":"Lancet Neurol"},{"key":"2465_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/jama.288.1.49","volume":"288","author":"Grady","year":"2002","unstructured":"Grady D, Herrington D, Bittner V et al. (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II). JAMA 288: 99\u2013101","journal-title":"JAMA"},{"key":"2465_CR20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"Hart","year":"1999","unstructured":"Hart R, Benavente O, McBride R et al. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131: 492\u2013501","journal-title":"Ann Intern Med"},{"key":"2465_CR21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.57.3.326","volume":"57","author":"Hart","year":"2000","unstructured":"Hart RG, Halperin JL, McBride R et al. (2000b) Aspirin for the primary prevention of stroke and other major vascular events. Meta-analysis and hypotheses. Arch Neurol 57: 326\u2013332","journal-title":"Arch Neurol"},{"key":"2465_CR22","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","volume":"115","author":"Hylek","year":"2007","unstructured":"Hylek EM, Evans-Molina C, Shea C et al. (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115: 2689\u20132696","journal-title":"Circulation"},{"key":"2465_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1993.03500020066033","volume":"269","author":"Kawachi","year":"1993","unstructured":"Kawachi I, Colditz GA, Stampfer MJ et al. (1993) Smoking cessation and decreased risk of stroke in women. JAMA 269: 232\u2013236","journal-title":"JAMA"},{"key":"2465_CR24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"LaRosa","year":"2005","unstructured":"LaRosa JC, Grundy SM, Waters DD et al. (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352: 1425\u20131435","journal-title":"N Engl J Med"},{"key":"2465_CR25","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.STR.30.12.2535","volume":"30","author":"Leppala","year":"1999","unstructured":"Leppala JM, Virtamo J, Fogelholm R et al. (1999) Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 30: 2535\u20132540","journal-title":"Stroke"},{"key":"2465_CR26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2165\/00003495-200767070-00001","volume":"67","author":"L\u00fcders","year":"2007","unstructured":"L\u00fcders S (2007) Drug therapy for the secondary prevention of stroke in hypertensive patients. Current issues and options. Drugs 67: 955\u2013963","journal-title":"Drugs"},{"key":"2465_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/10641969609088983","volume":"18","author":"MacMahon","year":"1996","unstructured":"MacMahon S, Rodgers A (1996) Primary and secondary prevention of stroke. Clin Exp Hypertens 18: 537\u2013546","journal-title":"Clin Exp Hypertens"},{"key":"2465_CR28","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"Murray","year":"1997","unstructured":"Murray CJL, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study. Lancet 349: 1498\u20131504","journal-title":"Lancet"},{"key":"2465_CR29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"Progress","year":"2001","unstructured":"Progress Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033\u20131041","journal-title":"Lancet"},{"key":"2465_CR30","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","volume":"34","author":"Rashid","year":"2003","unstructured":"Rashid P, Leonardi-Bee J, Bath P (2003) Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review. Stroke 34: 2741\u20132749","journal-title":"Stroke"},{"key":"2465_CR31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(04)15785-1","volume":"363","author":"Rothwell","year":"2004","unstructured":"Rothwell P, Eliasziw M, Gutnikov S et al. (2004) Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363: 915\u2013924","journal-title":"Lancet"},{"key":"2465_CR32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","volume":"36","author":"Schrader","year":"2005","unstructured":"Schrader J, L\u00fcders S, Kulschewski A et al. (2005) Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36: 1218\u20131226","journal-title":"Stroke"},{"key":"2465_CR33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","volume":"34","author":"Schrader","year":"2003","unstructured":"Schrader J, L\u00fcders S, Kulschewski A et al. (2003) The ACCESS Study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34: 1699\u20131703","journal-title":"Stroke"},{"key":"2465_CR34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","volume":"347","author":"Skoog","year":"1996","unstructured":"Skoog I, Lernfelt B, Landahl S et al. (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141\u20131145","journal-title":"Lancet"},{"key":"2465_CR35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","volume":"358","author":"Staessen","year":"2001","unstructured":"Staessen JA, Wang JG, Thijs L (2001) Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 358: 1305\u20131315","journal-title":"Lancet"},{"key":"2465_CR36","unstructured":"Statistisches Bundesamt (2005) Statistisches Jahrbuch 2005 f\u00fcr die Bundesrepublik Deutschland. Wiesbaden"},{"key":"2465_CR37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","volume":"291","author":"Toole","year":"2004","unstructured":"Toole JF, Malinow MR, Chambless LE et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565\u2013575","journal-title":"JAMA"},{"key":"2465_CR38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854\u2013865","journal-title":"Lancet"},{"key":"2465_CR39","first-page":"602","volume":"354","author":"UK","year":"1999","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1999) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 354: 602","journal-title":"Lancet"},{"key":"2465_CR40","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/01.STR.31.8.1882","volume":"31","author":"Wannamethee","year":"2000","unstructured":"Wannamethee SG, Shaper AG, Ebrahim S (2000) HDL-Cholesterol, total cholesterol and the risk of stroke in middle-aged British men. Stroke 31: 1882\u20131888","journal-title":"Stroke"},{"key":"2465_CR41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-1331.2004.00949.x","volume":"12","author":"Ward","year":"2005","unstructured":"Ward A, Payne KA, CaroJJ et al. (2005) Care Needs and Economic Consequences After Acute Ischemic Stroke: the Erlangen Stroke Project. Eur J Neurol 12: 264\u2013267","journal-title":"Eur J Neurol"},{"key":"2465_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(98)90089-7","volume":"352","author":"Wolf","year":"1998","unstructured":"Wolf PA (1998) Prevention of stroke. Lancet 352: 3\u20134","journal-title":"Lancet"},{"key":"2465_CR43","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","volume":"359","author":"Yusuf","year":"2008","unstructured":"Yusuf S, Diener HC, Sacco RL et al. (2008) Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 359: 1225\u20131237","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2465-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-009-2465-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2465-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:15Z","timestamp":1558584735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-009-2465-0"}},"subtitle":["Was ist evidenzbasiert?"],"short-title":[],"issued":{"date-parts":[[2009,11,11]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["2465"],"URL":"https:\/\/doi.org\/10.1007\/s00108-009-2465-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,11]]}}}